TransMedics reports Q3 EPS of $0.46, revenue of $203 million
TransMedics Group reported Q3 revenue of $203 million versus the IBES estimate of $177.6 million.
TransMedics Group reported Q3 revenue of $203 million versus the IBES estimate of $177.6 million.